Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Knowing when to adjust your financial plan can significantly impact your financial success. Learn key indicators for making timely adjustments.
23,637 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Even a $1 million nest egg isn’t a guaranteed shield. With rising health costs, longer lifespans, and market swings, ...
MLB owners rolled out a formal salary cap plan, marking a rare shift in labor talks as the 2027 season looms. The mov...
JPMorgan's Nasdaq Equity Premium Income ETF offers a high monthly yield around 10% but carries equity risk. This arti...
Retiring to Cape Coral with a $900,000 portfolio and a waterfront home sounds idyllic, but the true cost includes tax...
As SoFi expands beyond student loan refi, the question for investors is clear: where will SoFi Technologies be in fiv...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
Navitas Semiconductor is making headlines as its stock climbs. This piece breaks down why navitas semiconductor stock...
Most retirees claim Social Security earlier than optimal, reducing lifetime income by thousands each year. Experts wa...
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
When a Lincoln Educational director sold a sizable block of shares, investors took note. This article breaks down the...
SpaceX is pursuing a bold mix of rockets, Starlink, and AI infrastructure. Yet heavy capital needs and a large debt l...